Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05799326 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy of Levofloxacin for Acute Ischemic Stroke

StatusRecruiting
PhaseNot applicable
SponsorYi Yang
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 2, 2024 (before its estimated December 30, 2024 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jun 30, 2024 to Dec 30, 2024
    • Study completion date: Sep 30, 2024 to Dec 30, 2024
    v5
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary endpoints: 2 to 1
    • Study sites: 0 to 1
    • Eligibility criteria expanded, about 2 words
    v4
  3. Start date: Mar 31, 2023 to Jun 30, 2023
    • Primary completion date: Mar 31, 2024 to Jun 30, 2024
    • Study completion date: Jun 30, 2024 to Sep 30, 2024
    • Eligibility criteria shortened, about 4 words
    v3
  4. Study title shortened, about 5 wordsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Yi Yang
17 trials monitored
See all monitored trials
Stroke
3,531 trials monitored
See 153 trials at risk
The purpose of this study is to determine the efficacy and safety of levofloxacin in treating acute ischemic stroke.
Trial Details
NCT Number NCT05799326
Lead Sponsor Yi Yang
Conditions
(from sponsor)		 Acute Ischemic Stroke
Related terms Ischemic Stroke
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov